(Q52872813)

9 May 2018

title

Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy. (English)

1 reference

9 May 2018

author

Carsten Denkert

3

1 reference

9 May 2018

Thomas Karn

14

1 reference

9 May 2018

Peter A. Fasching

5

object named as

P A Fasching

1 reference

9 May 2018

2

S Loibl

1 reference

9 May 2018

17

M Untch

1 reference

9 May 2018

J L Lindner

1

1 reference

9 May 2018

B Ataseven

4

1 reference

9 May 2018

B M Pfitzner

6

1 reference

9 May 2018

B Gerber

7

1 reference

9 May 2018

S Gade

8

1 reference

9 May 2018

S Darb-Esfahani

9

1 reference

9 May 2018

B V Sinn

10

1 reference

9 May 2018

J Huober

11

1 reference

9 May 2018

K Engels

12

1 reference

9 May 2018

H Tesch

13

1 reference

9 May 2018

F Pommerenke

15

1 reference

9 May 2018

C Liedtke

16

1 reference

9 May 2018

V Müller

18

1 reference

9 May 2018

B Rack

19

1 reference

9 May 2018

C Schem

20

1 reference

9 May 2018

G von Minckwitz

21

1 reference

9 May 2018

publication date

29 October 2014

1 reference

9 May 2018

published in

Annals of Oncology

1 reference

9 May 2018

volume

26

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

page(s)

95-100

1 reference

9 May 2018

SPARC and tumor growth: where the seed meets the soil?

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

The regulatory function of SPARC in vascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

SPARC, a matricellular glycoprotein with important biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Response-guided neoadjuvant chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

nab-Paclitaxel mechanisms of action and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU487

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDU487

1 reference

9 May 2018

PubMed ID

25355716

1 reference

9 May 2018